TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/9/16 17:38 | 11/9/16 | GNCA | Genocea Biosciences, Inc. | Health | BioPrd | Biological Products, (No Diag | Hetherington Seth V | MA | O | Chief Me | M.d | 10 | 2.02 | 1 | 5 | 24 | 26 | D | -58 | -40 | -1 | -21 | -36 | -9 | 1 | 10 | 8 | 17 | 12 | 20 | 60 | ||
12/15/15 17:59 | 12/11/15 | GNCA | Genocea Biosciences, Inc. | Health | BioPrd | Biological Products, (No Diag | Hetherington Seth V | MA | O | Chief Me | M.d | 10 | 2.02 | 1 | 5 | 31 | 21 | D | -30 | -55 | -41 | 16 | -4 | -9 | -2 | 5 | -1 | -45 | -30 | -36 | -35 | ||
8/11/15 16:17 | 8/7/15 | GNCA | Genocea Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hetherington Seth V | MA | O | Chief Me | M.d | 10 | 2.02 | 3 | 5 | 45 | 16 | D | -3 | 43 | 39 | -1 | -15 | 0 | -3 | 3 | 4 | -16 | -48 | -76 | -59 | |
8/20/14 16:10 | 8/18/14 | GNCA | Genocea Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hetherington Seth V | MA | O | Chief Me | M.d | 22 | 2.02 | 1 | 11 | New | 11 | D | 13 | -26 | -15 | -19 | 3 | 5 | 1 | 0 | -9 | -31 | -31 | -3 | ||
1/11/06 17:02 | 1/10/06 | INHX | Inhibitex Inc | Health | BioPrd | Biological Products, (No Diag | Hetherington Seth V | GA | O | VP,Clini | S.d | -75 | 9.00 | 0 | -8 | -100 | 0 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |